| NOVOZYMES AS NAM. B DK 2 |
| Dänemark |
| Chemie |
| DK0060336014 / A1JP9Y |
| NZM2 (Frankfurt) |
| FRA:NZM2, ETR:NZM2, NZM2:GR |
| - |
| https://www.novonesis.com.. |
|
Novonesis (Novozymes) B is the Class B share of Novonesis A/S, a leading biotechnology company headquartered in Lyngby, Denmark. Formed in 2024 through the merger of Novozymes and Chr. Hansen, it holds a dominant near-50% market share in industrial e..
>Volltext.. |
| 25563.12 Mio. EUR |
| 28412.27 Mio. EUR |
| 4139.55 Mio. EUR |
| 1448.23 Mio. EUR |
| 588.24 Mio. EUR |
| 1.26 EUR |
| 3169.29 Mio. EUR |
| 322.82 Mio. EUR |
| 1263.69 Mio. EUR |
| 0.27 |
| 3.22% |
| 29.8% |
| 1.44 EUR |
| 1.57% |
| 1.56% |
| 24.03.26 - 0.5686627€ 20.03.26 - 0.5688413€ >weitere anzeigen... |
| - |
| NOVOZYMES, NOVONESIS |
| 20.08.26 |
|
||||
|
||||
|